FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309458225> ?p ?o ?g. }

• W4309458225 endingPage "14227" @default.
• W4309458225 startingPage "14227" @default.
• W4309458225 abstract "Sarcomas are rare malignant mesenchymal neoplasms, and the knowledge of tumor biology and genomics is scarce. Chemotherapy is the standard of care in advanced disease, with poor outcomes. Identifying actionable genomic alterations may offer effective salvage therapeutic options when previous lines have failed. Here, we report a retrospective cohort study of sarcoma patients followed at our center and submitted to comprehensive genomic profiling between January 2020 and June 2021. Thirty patients were included, most (96.7%) with reportable genomic alterations. The most common alterations were linked to cell cycle regulation (TP53, CDKN2A/B, and RB1 deletions and CDK4, MDM2, and MYC amplifications). Most patients (96.7%) had microsatellite stability and low tumor mutational burden (≤10 muts/megabase (Mb); median 2 Muts/Mb). Two-thirds of patients had actionable mutations for targeted treatments, including five cases with alterations amenable to targeted therapies with clinical benefit within the patient's tumor type, ten cases with targetable alterations with clinical benefit in other tumor types, and five cases with alterations amenable to targeting with drugs under investigation in a clinical trial setting. A significant proportion of cases in this study had actionable genomic alterations with available targeted drugs. Next-generation sequencing is a feasible option for identifying molecular drivers that can provide therapeutic options for individual patients. Molecular Tumor Boards should be implemented in the clinical practice to discuss genomic findings and inform clinically relevant targeted therapies." @default.
• W4309458225 created "2022-11-28" @default.
• W4309458225 creator A5009833622 @default.
• W4309458225 creator A5023653574 @default.
• W4309458225 creator A5024006012 @default.
• W4309458225 creator A5049712000 @default.
• W4309458225 creator A5062385123 @default.
• W4309458225 creator A5072527738 @default.
• W4309458225 creator A5074465843 @default.
• W4309458225 date "2022-11-17" @default.
• W4309458225 modified "2023-09-30" @default.
• W4309458225 title "Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal" @default.
• W4309458225 cites W1970754922 @default.
• W4309458225 cites W1982253551 @default.
• W4309458225 cites W2062398277 @default.
• W4309458225 cites W2088303301 @default.
• W4309458225 cites W2140334256 @default.
• W4309458225 cites W2140460887 @default.
• W4309458225 cites W2171346054 @default.
• W4309458225 cites W2336280232 @default.
• W4309458225 cites W2560827811 @default.
• W4309458225 cites W2604733575 @default.
• W4309458225 cites W2606495925 @default.
• W4309458225 cites W2765468373 @default.
• W4309458225 cites W2800425854 @default.
• W4309458225 cites W2800642986 @default.
• W4309458225 cites W2805725835 @default.
• W4309458225 cites W2897815318 @default.
• W4309458225 cites W2900082702 @default.
• W4309458225 cites W2909679049 @default.
• W4309458225 cites W2941170263 @default.
• W4309458225 cites W3006180292 @default.
• W4309458225 cites W3012077769 @default.
• W4309458225 cites W3033196316 @default.
• W4309458225 cites W3083986479 @default.
• W4309458225 cites W3110376305 @default.
• W4309458225 cites W3114276917 @default.
• W4309458225 cites W3164791653 @default.
• W4309458225 cites W3197355167 @default.
• W4309458225 cites W4200569669 @default.
• W4309458225 cites W4211038654 @default.
• W4309458225 cites W4244970282 @default.
• W4309458225 cites W4285097283 @default.
• W4309458225 cites W4285586388 @default.
• W4309458225 cites W772589830 @default.
• W4309458225 doi "https://doi.org/10.3390/ijms232214227" @default.
• W4309458225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36430703" @default.
• W4309458225 hasPublicationYear "2022" @default.
• W4309458225 type Work @default.
• W4309458225 citedByCount "0" @default.
• W4309458225 crossrefType "journal-article" @default.
• W4309458225 hasAuthorship W4309458225A5009833622 @default.
• W4309458225 hasAuthorship W4309458225A5023653574 @default.
• W4309458225 hasAuthorship W4309458225A5024006012 @default.
• W4309458225 hasAuthorship W4309458225A5049712000 @default.
• W4309458225 hasAuthorship W4309458225A5062385123 @default.
• W4309458225 hasAuthorship W4309458225A5072527738 @default.
• W4309458225 hasAuthorship W4309458225A5074465843 @default.
• W4309458225 hasBestOaLocation W43094582251 @default.
• W4309458225 hasConcept C104317684 @default.
• W4309458225 hasConcept C121608353 @default.
• W4309458225 hasConcept C126322002 @default.
• W4309458225 hasConcept C141231307 @default.
• W4309458225 hasConcept C142724271 @default.
• W4309458225 hasConcept C143998085 @default.
• W4309458225 hasConcept C180754005 @default.
• W4309458225 hasConcept C189206191 @default.
• W4309458225 hasConcept C2778256501 @default.
• W4309458225 hasConcept C2779134260 @default.
• W4309458225 hasConcept C2779767149 @default.
• W4309458225 hasConcept C2780265364 @default.
• W4309458225 hasConcept C2781230642 @default.
• W4309458225 hasConcept C2994067223 @default.
• W4309458225 hasConcept C502942594 @default.
• W4309458225 hasConcept C535046627 @default.
• W4309458225 hasConcept C54355233 @default.
• W4309458225 hasConcept C60644358 @default.
• W4309458225 hasConcept C61320498 @default.
• W4309458225 hasConcept C71924100 @default.
• W4309458225 hasConcept C86803240 @default.
• W4309458225 hasConceptScore W4309458225C104317684 @default.
• W4309458225 hasConceptScore W4309458225C121608353 @default.
• W4309458225 hasConceptScore W4309458225C126322002 @default.
• W4309458225 hasConceptScore W4309458225C141231307 @default.
• W4309458225 hasConceptScore W4309458225C142724271 @default.
• W4309458225 hasConceptScore W4309458225C143998085 @default.
• W4309458225 hasConceptScore W4309458225C180754005 @default.
• W4309458225 hasConceptScore W4309458225C189206191 @default.
• W4309458225 hasConceptScore W4309458225C2778256501 @default.
• W4309458225 hasConceptScore W4309458225C2779134260 @default.
• W4309458225 hasConceptScore W4309458225C2779767149 @default.
• W4309458225 hasConceptScore W4309458225C2780265364 @default.
• W4309458225 hasConceptScore W4309458225C2781230642 @default.
• W4309458225 hasConceptScore W4309458225C2994067223 @default.
• W4309458225 hasConceptScore W4309458225C502942594 @default.
• W4309458225 hasConceptScore W4309458225C535046627 @default.
• W4309458225 hasConceptScore W4309458225C54355233 @default.
• W4309458225 hasConceptScore W4309458225C60644358 @default.

• next